UCB SA (UCB.BR)

EUR 169.2

(5.0%)

Operating Expenses Summary of UCB SA

  • UCB SA's latest annual operating expenses in 2023 was 2.94 Billion EUR , down -5.87% from previous year.
  • UCB SA's latest quarterly operating expenses in 2024 Q2 was 1.61 Billion EUR , down 0.0% from previous quarter.
  • UCB SA reported a annual operating expenses of 3.25 Billion EUR in annual operating expenses 2022, up 7.82% from previous year.
  • UCB SA reported a annual operating expenses of 3.01 Billion EUR in annual operating expenses 2021, up 6.57% from previous year.
  • UCB SA reported a quarterly operating expenses of 1.2 Billion EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly operating expenses of 3.06 Billion EUR for 2023 FY, down -5.87% from previous quarter.

Annual Operating Expenses Chart of UCB SA (2023 - 2002)

Historical Annual Operating Expenses of UCB SA (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 2.94 Billion EUR -5.87%
2022 3.25 Billion EUR 7.82%
2021 3.01 Billion EUR 6.57%
2020 2.83 Billion EUR 17.9%
2019 2.4 Billion EUR 1.22%
2018 2.37 Billion EUR 5.75%
2017 2.24 Billion EUR 5.5%
2016 2.12 Billion EUR -3.89%
2015 2.21 Billion EUR 6.14%
2014 2.08 Billion EUR 8.2%
2013 1.92 Billion EUR -0.26%
2012 1.93 Billion EUR 5.98%
2011 1.82 Billion EUR 7.36%
2010 1.69 Billion EUR 60.95%
2009 1.05 Billion EUR -44.76%
2008 1.91 Billion EUR -8.0%
2007 2.07 Billion EUR 49.89%
2006 1.38 Billion EUR 1.84%
2005 1.36 Billion EUR -35.92%
2004 2.12 Billion EUR 11.05%
2003 1.91 Billion EUR 721.76%
2002 -307.36 Million EUR 0.0%

Peer Operating Expenses Comparison of UCB SA

Name Operating Expenses Operating Expenses Difference
Nicox S.A. -11.5 Million EUR 25667.243%
European Medical Solutions 13.64 Million EUR -21450.524%
FERMENTALG 12.34 Million EUR -23725.34%
argenx SE 1.34 Billion EUR -119.044%
BioSenic S.A. 7.58 Million EUR -38684.122%
Celyad Oncology SA 8.49 Million EUR -34540.754%
Hyloris Pharmaceuticals SA 17.98 Million EUR -16250.698%
Onward Medical N.V. 20.64 Million EUR -14145.58%
Oxurion NV 12.21 Million EUR -23978.926%
PHAXIAM Therapeutics S.A. 24.98 Million EUR -11670.592%
Financière de Tubize SA 114.38 Thousand EUR -2570951.412%